The first daily tablet to treat endometriosis symptoms is approved in England. However, it is only for patients who have tried all other options but have not done anything.

Endometriosis is a disease in which the tissue similar to the lining of the uterus grows outside the uterus. It causes severe pain in the pelvis and makes it difficult to become pregnant.

According to the World Health Organization (WHO), a person’s first menstrual period can begin and may be final until menopause. Symptoms of endometriosis include pain during the period, intestinal movements, urination, your lower abdominal pain, pain after sex, fatigue, shortness of breath, low mood, anxiety and difficulty in getting pregnant.

It is considered to affect one of the 10 women of reproductive age.

The new tablet, called the Relugolix Comboltion Therapy, is approved by the UK drug Regulating Body The National Institute of Health and Care Excellence (NICE).

Unlike many injectable remedies, the pill helps with home treatment and works much often without the problem of going to the doctor.

New combination therapy pills, riluGolix-astradiol-neorathisterone, work by blocking hormones that make the condition worse and then provide the required replacement hormones required to improve the condition.

According to a BBC report, it is available only to those who have tried other treatment and surgery without success through NHS (National Health Service) in England. These treatments include hormonal contraceptives and intrauterine distribution systems. About 1,000 women in England will be able to use pills.

Known as the “First-of-a-Mind” treatment, initially rejected by the National Institute for Health and Care Excellence (NICE), the tablet eliminates the need for several drugs and makes regular visits to the clinics for injections.

“Instead of traveling clinics for injection, now there is a daily tablet that can be taken at home. Treatment can also be prevented and can be started more easily, especially important for planning and management of side effects. This feature not only gives benefits to patients, but also reduces pressure on NHS services, but reduces pressure on NHS services,” Helen Night, Director of Medicine.

The National Clinical Director of NHS for women’s health, Dr. Suu Maan said that this first-type treatment for endometriosis will give women more control of their own health, requiring them in the comfort of their homes.